Human MTH1 bound to the inhibitor TH287 скачать в хорошем качестве

Human MTH1 bound to the inhibitor TH287

The Helleday Laboratory proudly presents a novel concept of treating cancer, based on a general non-oncogene addition in cancer cells. The new concept is that cancer cells are killed by their own high level of intrinsic oxidative stress, not present in normal cells. We target the MTH1 protein required to prevent oxidative stress in cancer to become DNA damage. Normal cells have low level of oxidative stress and don't need the MTH1 protein. See how the concept works! Learn more about our revolutionary anti-cancer approach here: http://www.helleday.org